We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+8.96%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$35.5B
AUM Growth
+$2.63B
Cap. Flow
-$358M
Cap. Flow %
-1.01%
Top 10 Hldgs %
19.61%
Holding
1,339
New
136
Increased
426
Reduced
527
Closed
93

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$78.4M
2
STLA icon
Stellantis
STLA
+$64.2M
3
AAPL icon
Apple
AAPL
+$56.5M
4
CINF icon
Cincinnati Financial
CINF
+$36.6M
5
MA icon
Mastercard
MA
+$33.9M

Top Sells

Rank Stock Value
1
PFPT
Proofpoint, Inc.
PFPT
+$121M
2
EPAM icon
EPAM Systems
EPAM
+$65.3M
3
NVDA icon
NVIDIA
NVDA
+$47.2M
4
VLO icon
Valero Energy
VLO
+$46.8M
5
AMAT icon
Applied Materials
AMAT
+$46.6M

Sector Composition

Rank Sector Weight
1 Technology 30.03%
2 Healthcare 16.84%
3 Consumer Discretionary 12.32%
4 Financials 10.53%
5 Industrials 8.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLMR icon
426
Palomar
PLMR
$3.79B
$14.6M 0.04%
193,640
-1,840
-0.9% -$133K
PCAR icon
427
PACCAR
PCAR
$70.5B
$14.6M 0.04%
244,793
+10,046
+4% +$616K
DNLI icon
428
Denali Therapeutics
DNLI
$3.79B
$14.3M 0.04%
182,700
+5,722
+3% +$354K
ONC
429
BeOne Medicines Ltd
ONC
$33.9B
$14.3M 0.04%
41,690
-4,972
-11% -$1.65M
BL icon
430
BlackLine
BL
$1.9B
$14.3M 0.04%
128,561
-19,608
-13% -$2.14M
GWW icon
431
W.W. Grainger
GWW
$64.2B
$14.3M 0.04%
32,617
-968
-3% -$427K
VRSN icon
432
VeriSign
VRSN
$26.3B
$14.2M 0.04%
62,329
-190
-0.3% -$41.4K
TPIC
433
DELISTED
TPI Composites
TPIC
$14.2M 0.04%
292,334
+28,758
+11% +$1.41M
LFT
434
Lument Finance Trust
LFT
$38.6M
$14.1M 0.04%
3,340,780
MAA icon
435
Mid-America Apartment Communities
MAA
$16B
$13.9M 0.04%
82,558
+496
+0.6% +$79K
FDX icon
436
FedEx
FDX
$73B
$13.9M 0.04%
46,600
+8,813
+23% +$2.62M
PSX icon
437
Phillips 66
PSX
$82.9B
$13.8M 0.04%
160,987
-407,202
-72% -$34.4M
IQV icon
438
IQVIA
IQV
$40.7B
$13.8M 0.04%
56,808
-79
-0.1% -$18.2K
MKC icon
439
McCormick & Company Non-Voting
MKC
$14B
$13.8M 0.04%
155,840
+15,413
+11% +$1.37M
CMA
440
DELISTED
Comerica
CMA
$13.7M 0.04%
+192,300
New +$14.3M
CVSA
441
Covista Inc
CVSA
$4.55B
$13.6M 0.04%
382,553
+7,451
+2% +$280K
VMC icon
442
Vulcan Materials
VMC
$36.8B
$13.6M 0.04%
78,159
-2,241
-3% -$401K
COLD icon
443
Americold
COLD
$4.21B
$13.5M 0.04%
357,850
-6,000
-2% -$232K
MCK icon
444
McKesson
MCK
$104B
$13.5M 0.04%
70,723
+12,903
+22% +$2.49M
EME icon
445
Emcor
EME
$29.9B
$13.5M 0.04%
109,400
-800
-0.7% -$97.6K
PCTY icon
446
Paylocity
PCTY
$7.75B
$13.4M 0.04%
70,363
-9,100
-11% -$1.64M
AN icon
447
AutoNation
AN
$7.7B
$13.4M 0.04%
141,200
-4,900
-3% -$480K
BILI icon
448
Bilibili
BILI
$7.75B
$13.3M 0.04%
108,900
+2,900
+3% +$314K
AXDX
449
DELISTED
Accelerate Diagnostics
AXDX
$13.2M 0.04%
163,551
+914
+0.6% +$72.7K
CTVA icon
450
Corteva
CTVA
$60.5B
$13.2M 0.04%
297,170
+29,105
+11% +$1.34M

Similar funds

Axa's Q2 2021 Portfolio in Review

As of Q2 2021, Axa held 1,339 positions worth $35.5B, up 8% from $32.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Axa's Q2 2021 filing shows 136 new, 426 increased, 527 reduced and 93 closed positions. Its largest new stake was Sprinklr: 1,100,000 shares worth $22.6M. The largest sale was Proofpoint, Inc., an estimated $121M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q2 2021 buy was Sprinklr: 1,100,000 shares worth $22.6M.
  • Axa added most to Berkshire Hathaway Class B in Q2 2021, an estimated $78.4M increase.
  • Axa's biggest Q2 2021 reduction was Proofpoint, Inc., cutting an estimated $121M.
  • Axa fully exited Arthur J. Gallagher & Co in Q2 2021, selling an estimated $33.5M.
  • Axa's ten largest holdings make up 20% of its $35.5B portfolio in Q2 2021.
  • Axa opened 136 new positions and closed 93 in Q2 2021.
  • Axa's portfolio value rose 8% quarter-over-quarter to $35.5B.

Based on Axa's 13F filing for Q2 2021, filed 13 Aug 2021.